Showing results (11-20 of 253) with videos related to
Sort By:
Pageof 26
Talanta|August 17, 2020
Improving sensitivity for the targeted LC-MS/MS analysis of the peptide bradykinin using a design of experiments approachTanja Gangnus, Bjoern B BurckhardtJournal of Pharmaceutical and Biomedical Analysis|September 2, 2020
Validated mass spectrometric assay for the quantification of substance P and human hemokinin-1 in plasma samples: A design of experiments concept for comprehensive method developmentMartin Feickert, Bjoern B BurckhardtAnalytical and Bioanalytical Chemistry|March 11, 2021
Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin systemTanja Gangnus, Bjoern B BurckhardtJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 2, 2019
A concept to make low-abundance endogenous renin accessible to mass spectrometry: A multistep experimental design approachIlja Burdman, Bjoern B BurckhardtRapid Communications in Mass Spectrometry : RCM|August 27, 2020
Human prorenin determination by hybrid immunocapture liquid chromatography/mass spectrometry: A mixed-solvent-triggered digestion utilizing D-optimal designIlja Burdman, Bjoern B BurckhardtScientific Reports|February 5, 2021
Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19Tanja Gangnus, Bjoern B BurckhardtJournal of Separation Science|November 22, 2019
A design of experiments concept for the minimization of nonspecific peptide adsorption in the mass spectrometric determination of substance P and related hemokinin-1Martin Feickert, Bjoern B BurckhardtPeptides|November 28, 2020
Mass spectrometric studies on the peptide integrity of substance P and related human tachykinins in human biofluidsMartin Feickert, Bjoern B BurckhardtDrug Testing and Analysis|October 30, 2020
Low-volume LC-MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trialTanja Gangnus, Bjoern B Burckhardt, Pageof 26